Finding the right balance between efficacy and tolerability for TB treatment: the search continues
Int J Tuberc Lung Dis
.
2021 Jan 1;25(1):84-86.
doi: 10.5588/ijtld.20.0575.
Authors
A K J Maug
1
,
M A Hossain
1
,
M Gumusboga
2
,
T Decroo
3
,
W Mulders
2
,
S Braet
2
,
J Buyze
2
,
D A Jiménez
2
,
C Schurmans
2
,
N Herssens
2
,
T Demeulenaere
4
,
L Lynen
2
,
B C de Jong
2
,
A Van Deun
5
Affiliations
1
Damien Foundation Bangladesh, Dhaka, Bangladesh.
2
Institute of Tropical Medicine, Antwerp, Belgium.
3
Institute of Tropical Medicine, Antwerp, Belgium, Research Foundation Flanders, Brussels, Belgium.
4
Damien Foundation Bangladesh, Brussels, Belgium.
5
Independent Consultant, Leuven, Belgium, <email></email>, Email: avdeun@ext.itg.be.
PMID:
33384054
DOI:
10.5588/ijtld.20.0575
No abstract available
Publication types
Letter
MeSH terms
Antitubercular Agents / therapeutic use
Humans
Tuberculosis, Multidrug-Resistant* / drug therapy
Substances
Antitubercular Agents